In a strategic move that underscores Dubai Investments PJSC's commitment to expanding its global footprint, its wholly-owned subsidiary Globalpharma has signed a Memorandum of Understanding (MoU) with PrinceFarma, an Angola-based pharmaceutical distribution company. This collaboration is poised to significantly enhance the pharmaceutical distribution landscape in Angola, a nation actively investing in its healthcare infrastructure.

The MoU, signed by Mohammed Saeed Al Raqbani of Dubai Investments and Aziz Rahemani of PrinceFarma, aims to streamline regulatory alignment and establish robust commercial and distribution frameworks for Globalpharma's extensive portfolio in Angola. The partnership will focus on identifying priority therapeutic areas and developing structured pathways for market growth.

Dr. Basem Albarahmeh, CEO of Globalpharma, emphasized the company's dedication to broadening access to high-quality healthcare solutions. He noted that this partnership complements Globalpharma's plans to set up pharmaceutical manufacturing operations in DIP Angola, thereby reinforcing its position as a regional pharmaceutical powerhouse.

Aziz Rahemani, Managing Director of PrinceFarma, echoed this sentiment, highlighting the partnership's potential to significantly enhance access to essential medicines in Angola. By combining PrinceFarma's local expertise with Globalpharma's robust pharmaceutical portfolio, the collaboration aims to meet Angola's healthcare needs more effectively.

As Angola continues to bolster its healthcare infrastructure and pharmaceutical supply chains, Globalpharma is seizing opportunities for industry collaboration that support improved healthcare delivery and local capacity building. This strategic partnership not only aligns with Angola's healthcare ambitions but also positions Globalpharma as a key player in the region's pharmaceutical sector.

For investors, this development signals a promising horizon for Dubai Investments. The company's strategic expansion into emerging markets like Angola, coupled with its focus on healthcare—a sector with perennial demand—augurs well for sustainable growth. Given the potential for increased market share and revenue, investors might consider holding their position in Dubai Investments as the company continues to capitalize on these growth opportunities.